The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions
Abstract
The blood-brain barrier (BBB) is composed mainly of specialized endothelial cells characterized by the presence of intercellular tight junctions. Additionally, perivascular cells, astrocytes, and surrounding basement membranes determine BBB integrity. BBB disruption is an early phenomenon in the formation of new white matter multiple sclerosis (MS) lesions; however, knowledge of the extent of BBB changes in gray matter MS lesions is lacking. Here, we studied several markers for BBB integrity in well-characterized brain tissue of patients with MS. Plasma protein leakage was enhanced in white matter lesions compared with that in normal-appearing white matter, whereas plasma protein leakage was absent in gray matter lesions. White matter lesions showed irregular basement membranes and parenchymal depositions of collagen type IV, whereas purely gray matter lesions lacked basement membrane alterations. Similarly, we observed no evidence for astrogliosis and tight junction changes in cortical MS lesions. Although BBB dysfunction is a common feature of white matter MS lesions, cortical MS lesions lack markers for BBB disruption or astrogliosis. Our data may indicate that BBB breakdown is not a critical event in the formation of gray matter MS lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This may well reflect the greater microglia and astrocyte activity in the white matter; pure cortical lesions in post-mortem tissues show little or no inflammation (Bo et al., 2004; Brink et al., 2005; van Horssen et al., 2007), although early lesions have been associated with prominent microglial activation (Lucchinetti et al., 2011).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as van Horssen et al., 2007
The cited source says what the claim attributes to it.
In the citing paper
“This may well reflect the greater microglia and astrocyte activity in the white matter; pure cortical lesions in post-mortem tissues show little or no inflammation (Bo et al., 2004; Brink et al., 2005; van Horssen et al., 2007), although early lesions have been associated with prominent microglial activation (Lucchinetti et al., 2011).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as van Horssen et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Self-citationThe blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Multiple sclerosis--the plaque and its pathogenesis.
Frohman, E., Racke, M., & Raine, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,793
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 1×
“All purely cortical lesions extended inward from the surface of the brain (Type III) (26).”
BackgroundSelf-citationRelapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757
Self-citationKERMODE, A. G., THOMPSON, A. J., TOFTS, P., MACMANUS, D. G., KENDALL, B. E., KINGSLEY, D. P. E., MOSELEY, I. F., RUDGE, P., & MCDONALD, W. I. (1990) · Brain · doi:10.1093/brain/113.5.1477 · Cited by 578
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
Bø, L., Vedeler, C. A., Nyland, H., Trapp, B. D., & Mørk, S. J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms917oa · Cited by 478
Self-citationThe Blood-Brain Barrier in Neuroinflammatory Diseases
de Vries, H. E., Kuiper, J., de Boer, A. G., van Berkel, T. J. C., & Breimer, D. D. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01320-6 · Cited by 430
Research works printed but not linked: 1
- 10.1093/brain/113.5.1477 · DOI · Paper page
Cited by
Sorted by citations
Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Stamatovic, S. M., Keep, R. F., & Andjelkovic, A. V. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777210 · Cited by 541
Grey matter pathology in multiple sclerosis
Geurts, J. J. G., & Barkhof, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70191-1 · Cited by 535
Association between pathological and MRI findings in multiple sclerosis
Filippi, M., Rocca, M. A., Barkhof, F., Brück, W., Chen, J. T., Comı, G., DeLuca, G. C., Stefano, N. D., Erickson, B. J., Evangelou, N., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70003-0 · Cited by 499
Lochhead, J. J., Yang, J., Ronaldson, P. T., & Davis, T. P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00914 · Cited by 445
Exploring the origins of grey matter damage in multiple sclerosis
Calabrese, M., Magliozzi, R., Ciccarelli, O., Geurts, J. J. G., Reynolds, R., & Martin, R. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3900 · Cited by 414
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 375
“…extend as well the cellular composition seems to differ between white and gray matter MS lesions (Bo et al., 2003; Albert et al., 2007; Van Horssen et al., 2007) the cuprizone model becomes increasingly attractive to study the underlying pathophysiological mechanisms of deand…”
BackgroundReadnower, R. D., Chavko, M., Adeeb, S., Conroy, M. D., Pauly, J. R., McCarron, R. M., & Sullivan, P. G. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22510 · Cited by 317
Measurement and clinical effect of grey matter pathology in multiple sclerosis
Geurts, J. J. G., Calabrese, M., Fisher, E., & Rudick, R. A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70230-2 · Cited by 304
Inflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D., Lassmann, H., & van Horssen, J. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 286
Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
Vercellino, M., Masera, S., Lorenzatti, M., Condello, C., Merola, A., Mattioda, A., Tribolo, A., Capello, E., Mancardi, G., Mutani, R., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a19a5a · Cited by 283
Cortical lesions in multiple sclerosis
Calabrese, M., Filippi, M., & Gallo, P. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.93 · Cited by 269
Regional differences between grey and white matter in cuprizone induced demyelination
Gudi, V., Moharregh-Khiabani, D., Skripuletz, T., Koutsoudaki, P. N., Kotsiari, A., Skuljec, J., Trebst, C., & Stangel, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.005 · Cited by 252
Relapsing and progressive forms of multiple sclerosis
Dutta, R., & Trapp, B. D. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000094 · Cited by 252
Complement C1q‐C3–associated synaptic changes in multiple sclerosis hippocampus
Michailidou, I., Willems, J., Kooi, E., van Eden, C. V., Gold, S., Geurts, J., Baas, F., Huitinga, I., & Ramaglia, V. (2015) · Annals of Neurology · doi:10.1002/ana.24398 · Cited by 226
Postmortem verification of MS cortical lesion detection with 3D DIR
Seewann, A., Kooi, E. J., Roosendaal, S. D., Pouwels, P. J. W., Wattjes, M. P., van der Valk, P., Barkhof, F., Polman, C. H., & Geurts, J. J. G. (2012) · Neurology · doi:10.1212/wnl.0b013e31824528a0 · Cited by 230
Cognitive Impairment in Multiple Sclerosis: Clinical, Radiologic and Pathologic Insights
DeLuca, G. C., Yates, R. L., Beale, H., & Morrow, S. A. (2014) · Brain Pathology · doi:10.1111/bpa.12220 · Cited by 228
Retinoic Acid Induces Blood–Brain Barrier Development
Mizee, M. R., Wooldrik, D., Lakeman, K. A. M., van het Hof, B., Drexhage, J. A. R., Geerts, D., Bugiani, M., Aronica, E., Mebius, R. E., Prat, A., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1338-12.2013 · Cited by 203
A 3‐year magnetic resonance imaging study of cortical lesions in relapse‐onset multiple sclerosis
Calabrese, M., Rocca, M., Atzori, M., Mattisi, I., Favaretto, A., Perini, P., Gallo, P., & Filippi, M. (2009) · Annals of Neurology · doi:10.1002/ana.21906 · Cited by 199
The Immunopathophysiology of Multiple Sclerosis
Wu, G. F., & Álvarez, E. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2010.12.009 · Cited by 186
Evolution of the blood–brain barrier in newly forming multiple sclerosis lesions
Gaitán, M. I., Shea, C. D., Evangelou, I. E., Stone, R. D., Fenton, K. M., Bielekova, B., Massacesi, L., & Reich, D. S. (2011) · Annals of Neurology · doi:10.1002/ana.22472 · Cited by 174
Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier
Spencer, J. I., Bell, J. S., & DeLuca, G. C. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316011 · Cited by 154
Schmierer, K., Parkes, H. G., So, P., An, S., Brandner, S., Ordidge, R. J., Yousry, T. A., & Miller, D. H. (2010) · Brain · doi:10.1093/brain/awp335 · Cited by 154
Grey matter pathology in multiple sclerosis
Bø, L., Geurts, J. J. G., Mörk, S., & van der Valk, P. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00615.x · Cited by 150
Self-citationClarner, T., Diederichs, F., Berger, K., Denecke, B., Gan, L., van der Valk, P., Beyer, C., Amor, S., & Kipp, M. (2012) · Glia · doi:10.1002/glia.22367 · Cited by 155
The pathological spectrum of CNS inflammatory demyelinating diseases
Hu, W., & Lucchinetti, C. F. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0178-z · Cited by 150
Blood brain barrier: A review of its anatomy and physiology in health and disease
Sharif, Y., Jumah, F., Coplan, L., Krosser, A., Sharif, Κ., & Tubbs, R. S. (2018) · Clinical Anatomy · doi:10.1002/ca.23083 · Cited by 151
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138
“…and astrocyte activity in the white matter; pure cortical lesions in post-mortem tissues show little or no inflammation (Bo et al. , 2004; Brink et al. , 2005; van Horssen et al. , 2007), although early lesions have been associated with prominent microglial activation (Lucchinetti et al. , 2011).”
Buschmann, J. P., Berger, K., Awad, H., Clarner, T., Beyer, C., & Kipp, M. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9773-x · Cited by 133
Magliozzi, R., Howell, O. W., Durrenberger, P. F., Aricò, E., James, R., Cruciani, C., Reeves, C., Roncaroli, F., Nicholas, R. S., & Reynolds, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1650-x · Cited by 131
Cortical pathology in multiple sclerosis
Stadelmann, C., Albert, M., Wegner, C., & Brück, W. (2008) · Current Opinion in Neurology · doi:10.1097/01.wco.0000318863.65635.9a · Cited by 129
Dulamea, A. O. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47861-6_7 · Cited by 128
Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy
Nakahara, J., Maeda, M., Aiso, S., & Suzuki, N. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8287-6 · Cited by 135
Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis
Seewann, A., Vrenken, H., Kooi, E., van der Valk, P., Knol, D. L., Polman, C. H., Pouwels, P. J. W., Barkhof, F., & Geurts, J. J. G. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511406575 · Cited by 120
Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis
Kooi, E., Geurts, J. J. G., van Horssen, J., Bø, L., & van der Valk, P. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b4bf8f · Cited by 115
Self-citationNeuropsychology of Multiple Sclerosis: Looking Back and Moving Forward
Benedict, R. H. B., DeLuca, J., Enzinger, C., Geurts, J. J. G., Krupp, L., & Rao, S. M. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000959 · Cited by 122
The extracellular matrix in multiple sclerosis pathology
van Horssen, J., Dijkstra, C. D., & de Vries, H. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04897.x · Cited by 114
Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex
Yates, R. L., Esiri, M. M., Palace, J. A., Jacobs, B. M., Perera, R., & DeLuca, G. C. (2017) · Annals of Neurology · doi:10.1002/ana.24997 · Cited by 111
Microglial interactions with the neurovascular system in physiology and pathology
Zhao, X., Eyo, U. B., Murugan, M., & Wu, L. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22576 · Cited by 112
Grey matter damage in multiple sclerosis
Klaver, R., de Vries, H. E., Schenk, G. J., & Geurts, J. J. G. (2013) · Prion · doi:10.4161/pri.23499 · Cited by 114
Gray matter pathology in (chronic) MS: Modern views on an early observation
Geurts, J. J. G., Stys, P. K., Minagar, A., Amor, S., & Zivadinov, R. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.01.018 · Cited by 106
Gudi, V., Škuljec, J., Yildiz, Ö., Frichert, K., Skripuletz, T., Moharregh-Khiabani, D., Voß, E., Wissel, K., Wolter, S., & Stangel, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022623 · Cited by 103
Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
Berghoff, S. A., Düking, T., Spieth, L., Winchenbach, J., Stumpf, S. K., Gerndt, N., Kusch, K., Ruhwedel, T., Möbius, W., & Saher, G. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0497-6 · Cited by 100
An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis
Mangiardi, M., Crawford, D. K., Xia, X., Du, S., Simon‐Freeman, R., Voskuhl, R. R., & Tiwari-Woodruff, S. K. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00444.x · Cited by 101
Bridges, L., Andoh, J., Lawrence, A. J., Khoong, C. H. L., Poon, W. W., Esiri, M. M., Markus, H. S., & Hainsworth, A. H. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000124 · Cited by 98
The Pathologic Substrate of Magnetic Resonance Alterations in Multiple Sclerosis
Lassmann, H. (2008) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2008.06.005 · Cited by 97
Gray matter imaging in multiple sclerosis: what have we learned?
Hulst, H. E., & Geurts, J. J. G. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-153 · Cited by 98
Pathology of Multiple Sclerosis
Kipp, M., van der Valk, P., & Amor, S. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712801661248 · Cited by 98
Tedeschi, E., Palma, G., Canna, A., Cocozza, S., Russo, C., Borrelli, P., Lanzillo, R., Angelini, V., Postiglione, E., Morra, V. B., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4245-2 · Cited by 87
Pathological differences between white and grey matter multiple sclerosis lesions
Prins, M., Schul, E., Geurts, J. J. G., van der Valk, P., Drukarch, B., & van Dam, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12841 · Cited by 89
Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
Gajofatto, A., Calabrese, M., Benedetti, M. D., & Monaco, S. (2013) · Disease Markers · doi:10.1155/2013/484959 · Cited by 83
Cortical remyelination is heterogeneous in multiple sclerosis
Strijbis, E. M. M., Kooi, E.-J., van der Valk, P., & Geurts, J. J. G. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx023 · Cited by 82
The blood–brain and gut–vascular barriers: from the perspective of claudins
Scalise, A. A., Kakogiannos, N., Zanardi, F., Iannelli, F., & Giannotta, M. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1926190 · Cited by 86
Gray matter damage in multiple sclerosis: Impact on clinical symptoms
van Munster, C. E. P., Jonkman, L. E., Weinstein, H. C., Uitdehaag, B. M. J., & Geurts, J. J. G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.006 · Cited by 82
Joshi, S., Ergin, A., Wang, M., Reif, R., Zhang, J. Y., Bruce, J. N., & Bigio, I. J. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0466-4 · Cited by 79
Calabrese, M., Favaretto, A., Martini, V., & Gallo, P. (2013) · Prion · doi:10.4161/pri.22580 · Cited by 91
Noumbissi, M. E., Galasso, B., & Stins, M. F. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0097-2 · Cited by 79
Increased expression of distinct galectins in multiple sclerosis lesions
Stancic, M., van Horssen, J., Thijssen, V. L., Gabius, H., van der Valk, P., Hoekstra, D., & Baron, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01184.x · Cited by 80
Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging
Gilmore, C., Geurts, J. J. G., Evangelou, N., Bot, J., van Schijndel, R. A., Pouwels, P. J. W., Barkhof, F., & Bø, L. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508096876 · Cited by 77
Self-citationBlood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis
Errede, M., Girolamo, F., Ferrara, G. B., Strippoli, M., Morando, S., Boldrin, V., Rizzi, M., Uccelli, A., Perris, R., Bendotti, C., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31826ac110 · Cited by 75
Functions of lipid raft membrane microdomains at the blood–brain barrier
Dodelet-Devillers, A., Cayrol, R., van Horssen, J., Haqqani, A. S., de Vries, H. E., Engelhardt, B., Greenwood, J., & Prat, A. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0488-6 · Cited by 71
Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis
Rajda, C., Pukoli, D., Bende, Z., Majláth, Z., & Vécsei, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020353 · Cited by 69
The Ins and Outs of Central Nervous System Inflammation—Lessons Learned from Multiple Sclerosis
Ramaglia, V., Rojas, O. L., Naouar, I., & Gommerman, J. L. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-124155 · Cited by 72
Clinical correlates of grey matter pathology in multiple sclerosis
Horáková, D., Kalinčík, T., Dušánková, J. B., & Doležal, O. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-10 · Cited by 68
Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study
Calabrese, M., Filippi, M., Rovaris, M., Mattisi, I., Bernardi, V., Atzori, M., Favaretto, A., Barachino, L., Rinaldi, L., Romualdi, C., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.06.028 · Cited by 73
Harrison, D. M., Oh, J., Roy, S., Wood, E. T., Whetstone, A., Seigo, M. A., Jones, C. K., Pham, D. L., van Zijl, P. C. M., Reich, D. S., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514558134 · Cited by 65
Markoullis, K., Sargiannidou, I., Schiza, N., Roncaroli, F., Reynolds, R., & Kleopa, K. A. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000106 · Cited by 63
The histopathology of grey matter demyelination in multiple sclerosis
Bø, L. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01216.x · Cited by 58
Self-citationHeterogeneity of cortical lesions in multiple sclerosis
Kooi, E., Strijbis, E. M. M., van der Valk, P., & Geurts, J. J. G. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b1c · Cited by 58
Investigation of leptomeningeal enhancement in MS
Eisele, P., Griebe, M., Szabo, K., Wolf, M. E., Alonso, A., Engelhardt, B., Hennerici, M. G., & Gass, A. (2015) · Neurology · doi:10.1212/wnl.0000000000001286 · Cited by 54
Eilam, R., Segal, M., Malach, R., Sela, M., Arnon, R., & Aharoni, R. (2018) · Glia · doi:10.1002/glia.23304 · Cited by 55
Ahmed, S. M., Fransen, N. L., Touil, H., Michailidou, I., Huitinga, I., Gommerman, J. L., Bar‐Or, A., & Ramaglia, V. (2022) · JCI Insight · doi:10.1172/jci.insight.151683 · Cited by 52
Disruption of the Blood-Brain Barrier During Neuroinflammatory and Neuroinfectious Diseases
Salimi, H., & Klein, R. S. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_7 · Cited by 56
The cuprizone model: regional heterogeneity of pathology
Wergeland, S., Torkildsen, Ø., Myhr, K., Mørk, S. J., & Bø, L. (2012) · APMIS · doi:10.1111/j.1600-0463.2012.02882.x · Cited by 52
Self-citationIntrathecal Inflammation in Progressive Multiple Sclerosis
Monaco, S., Nicholas, R. S., Reynolds, R., & Magliozzi, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218217 · Cited by 51
Loveless, S., Neal, J., Howell, O. W., Harding, K. E., Sarkies, P., Evans, R., Bevan, R. J., Hakobyan, S., Harris, C. L., Robertson, N. P., et al. (2017) · Brain Pathology · doi:10.1111/bpa.12546 · Cited by 48
Morgan, B. P., Gommerman, J. L., & Ramaglia, V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.600656 · Cited by 51
Brana, C., Frossard, M., Gobert, R. P., Martinier, N., Boschert, U., & Seabrook, T. J. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12048 · Cited by 45
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
Kreft, K. L., van Meurs, M., Wierenga‐Wolf, A. F., Melief, M., van Strien, M. E., Hol, E. M., Oostra, B. A., Laman, J. D., & Hintzen, R. Q. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0144-4 · Cited by 44
Initial investigation of the blood-brain barrier in MS lesions at 7 tesla
Gaitán, M. I., Sati, P., Inati, S., & Reich, D. S. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512471093 · Cited by 45
Human brain endothelial cells are responsive to adenosine receptor activation
Mills, J. H., Alabanza, L. M., Weksler, B. B., Couraud, P., Romero, I. A., & Bynoe, M. S. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9222-2 · Cited by 43
Breaking down the cellular responses to type I interferon neurotoxicity in the brain
Viengkhou, B., & Hofer, M. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110593 · Cited by 41
Liao, C., Cho, W.-L., Kao, T. C., SU, K. ‐., LIN, Y. ‐., & Fan, C. (2008) · Parasite Immunology · doi:10.1111/j.1365-3024.2008.01048.x · Cited by 40
Bian, W., Tranvinh, E., Tourdias, T., Han, M. H., Liu, T., Wang, Y., Rutt, B. K., & Zeineh, M. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4830 · Cited by 39
Prins, M., Dutta, R., Baselmans, B. M. L., Brevé, J. J. P., Bol, J. G. J. M., Deckard, S. A., van der Valk, P., Amor, S., Trapp, B. D., de Vries, H. E., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0098-6 · Cited by 41
Kap, Y. S., Bauer, J., van Driel, N., Bleeker, W. K., Parren, P. W. H. I., Kooi, E., Geurts, J. J. G., Laman, J. D., Craigen, J. L., Blezer, E. L. A., et al. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318234d421 · Cited by 36
Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and Variants
Dekker, I., & Wattjes, M. P. (2017) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2016.12.002 · Cited by 38
Grab, D. J., Chakravorty, S. J., van der Heyde, H., & Stins, M. F. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01661.x · Cited by 35
Breaching Brain Barriers: B Cell Migration in Multiple Sclerosis
Rodriguez-Mogeda, C., Rodríguez‐Lorenzo, S., Attia, J. V. D., van Horssen, J., Witte, M. E., & de Vries, H. E. (2022) · Biomolecules · doi:10.3390/biom12060800 · Cited by 36
Hashimoto, Y., Poirier, K., Boddaert, N., Hubert, L., Aubart, M., Kamińska, A., Alison, M., Desguerre, I., Münnich, A., & Campbell, M. (2022) · Brain · doi:10.1093/brain/awac215 · Cited by 35
Schmierer, K., Thavarajah, J. R., An, S., Brandner, S., Miller, D. H., & Tozer, D. J. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22381 · Cited by 37
Progressive Multiple Sclerosis and Gray Matter Pathology: An MRI Perspective
Inglese, M., Oesingmann, N., Casaccia, P., & Fleysher, L. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20247 · Cited by 38
The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study
Jonkman, L. E., Klaver, R., Fleysher, L., Inglese, M., & Geurts, J. J. G. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516635290 · Cited by 33
Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
Ward, L. A., Lee, D. S. W., Sharma, A. K., Wang, A. A., Naouar, I., Xianjie, I., Pikor, N. B., Nuesslein‐Hildesheim, B., Ramaglia, V., & Gommerman, J. L. (2019) · JCI Insight · doi:10.1172/jci.insight.132522 · Cited by 32
Iron in multiple sclerosis – Neuropathology, immunology, and real-world considerations
Zierfuss, B., Wang, Z., Jackson, A. N., Moezzi, D., & Yong, V. W. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104934 · Cited by 34
Macroglial diversity: white and grey areas and relevance to remyelination
Werkman, I. L., Lentferink, D. H., & Baron, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03586-9 · Cited by 33
van Schaik, P. E. M., Zuhorn, I. S., & Baron, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158418 · Cited by 35
Morphological and functional changes of blood–brain barrier in kindled rats with cortical dysplasia
Kaya, M., Gürses, C., Kalaycı, R., Ekizoğlu, O., Ahıshalı, B., Orhan, N., Oku, B., Arıcan, N., Üstek, D., Bılgıç, B., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.101 · Cited by 27
Neuropathology of multiple sclerosis
Amor, S., & van der Valk, P. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979088.003 · Cited by 28
Kapoor, T., & Mehan, S. (2020) · Current Drug Discovery Technologies · doi:10.2174/1570163817666200207100903 · Cited by 26
Metadata
- Authors
- van Horssen, J., Brink, B. P., de Vries, H. E., van der Valk, P., & Bø, L.
- Affiliations
- Vrije Universiteit Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Haukeland University Hospital (NO)
- Corresponding author
- van Horssen, Jack
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04
- Volume
- 66
- Issue
- 4
- Pages
- 321-328
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1968478844
- Cited by
- 187
- References
- 31
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 16 · 2016: 7 · 2015: 11 · 2014: 12 · 2013: 12 · 2012: 18
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- blood-brain barrier, multiple sclerosis, gray matter lesions, white matter lesions, plasma protein leakage, basement membrane, type IV collagen, astrocyte activation, tight junctions, endothelial cells, cortical lesions
- MeSH terms
- Adult, Aged, Basement Membrane, Blood-Brain Barrier, Cerebral Cortex, Female, Fibrinogen, Glial Fibrillary Acidic Protein, Humans, Immunoglobulin G, Immunohistochemistry, Male, Membrane Proteins, Middle Aged, Multiple Sclerosis, Tight Junctions, Collagen Type V, Claudin-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
